Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC.

Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice.

Listen as an expert pulmonologist provides a case-focused description of his approach to diagnosis and management of refractory chronic cough and discusses emerging therapies.

Listen as an expert in otolaryngology describes his approach to the diagnosis and management of refractory chronic cough and draws on a clinically relevant case to illustrate key points.

Listen in as Joseph Kim, MD, MPH, MBA, and Colten Bracken, MD, FAAFP, discuss lessons learned in improving obesity care by integrating comprehensive diabetes management to help patients improve their diabetes and achieve weight loss simultaneously.

In this podcast, listen as Dr Palak Trivedi catches you up on the most recent developments in primary biliary cholangitis (PBC) treatment, discussing cutting-edge data on new and emerging agents and providing insight into how these updates may be integrated into your practice. 

In this episode, dermatology experts discuss patient candidacy and treatment advancement strategies for using IL-13 inhibitors in atopic dermatitis, with key take-home points illustrated through a detailed patient case.

In this episode, dermatology experts discuss the current evidence for using IL-13 inhibitors for moderate to severe atopic dermatitis, with key take-home points illustrated through a detailed patient case.

Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; and Martha Grugel, MA, discuss lessons learned in improving obesity care by managing the prior authorization process—from clinic visit to denial appeals—for antiobesity medications.

In this episode, dermatology experts discuss the immunopathogenesis of atopic dermatitis, adaptive immunity, and the clinical manifestations of IL-13, illustrated through a detailed patient case.

Listen in as a pulmonology expert discusses the latest advances in non–cystic fibrosis bronchiectasis (NCFBE), including current treatment options, data on emerging agents, and how to personalize NCFBE management strategies to meet patients’ needs.

Listen in as Ty J. Gluckman, MD, MHA, discusses the pivotal phase III FINEARTS-HF trial and how the treatment landscape is evolving for patients with heart failure with mildly reduced or preserved ejection fraction, including the emerging role of mineralocorticoid receptor antagonists.

Listen in as a respiratory diseases expert and radiology expert discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE.

Listen in as Joseph Kim, MD, MPH, MBA, and Natalie Orbach, PA-C, discuss lessons learned in improving obesity care by implementing patient-centered and individualized treatment plans based on patients’ specific needs in nutrition, physical activity, mental health, and pharmacotherapy.

Listen as an allergy expert provides his perspectives on the recognition, burden, management, pathophysiology, and emerging treatment landscape of refractory chronic cough in the context of a clinically relevant case.

Listen in as 4 experts discuss their current screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including the necessary role of multidisciplinary care and early detection to improve outcomes.

Listen in as Joseph Kim, MD, MPH, MBA, and Sejal Desai, MD, DABOM, discuss lessons learned with developing and implementing obesity-related virtual support groups to engage and provide consistent support to patients on their weight loss journey.

Listen in as Joseph Kim, MD, MPH, MBA, and Sophia Kwon, MD, discuss lessons learned with implementing an obesity checklist as a documentation shortcut via the electronic health record to improve patient care without adding onto note fatigue or burnout among staff users.

In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss actionable strategies for healthcare professionals to put into practice regarding the care of patients with primary biliary cholangitis (PBC).

How should we manage primary biliary cholangitis (PBC) in people with high ALP levels? Listen to learn more about the role of ALP and the biochemical response in PBC management from expert faculty, Dr Stuart Gordon and Dr Nancy Reau, as they discuss an illustrative patient case and explain what to expect from treatment.